<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612845</url>
  </required_header>
  <id_info>
    <org_study_id>PI-523</org_study_id>
    <nct_id>NCT01612845</nct_id>
  </id_info>
  <brief_title>Effect of Platelet-rich Fibrin on Rotator Cuff Repair</brief_title>
  <acronym>PRP-Fibrin</acronym>
  <official_title>Platelet-Rich Fibrin for Arthroscopically Repaired Massive Rotator Cuff Tears: A Prospective Randomized Pilot Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>spanish society of orthopedics and traumatology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to prospectively evaluate the influence of local application
      of Platelet Rich Fibrin (PRF) on the functional outcome and integrity of the arthroscopically
      repaired tendons in patients with massive tears of the rotator cuff.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, randomized clinical trial was performed on 28 patients (22 females, 6 males)
      with an average age of 65 years (range, 53 to 77) undergoing complete arthroscopic repair of
      a massive rotator cuff tear. In 14 patients, after the repair was completed, 6 cc. of PRF
      (vivostat ®) were locally applied to the repair site. In 14 patients no addition of PRF was
      performed. All patients underwent an arthro-MRI to evaluate the integrity of the repair and a
      clinical exam one year after the operation. All patients were then followed clinically at a
      minimum of 2 years. Functional outcome was evaluated with the Constant and DASH scores.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rotator cuff tear healing rate after surgical reconstruction evaluated by arthro-MRI</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional outcome evaluated with constant score</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>disability outcome evaluated with dash score</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Rotator Cuff Tears of the Shoulder</condition>
  <arm_group>
    <arm_group_label>PRF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the group in which the PRF was administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>repair without PRF</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic repair without platelet rich fibrin</intervention_name>
    <description>after the tendon is repaired, no additional procedures are performed and no PRF is administered</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PRF (vivostat ®) administration after rotator cuff repair</intervention_name>
    <description>7cc. of autologous PRF are locally administered to the repair site after reconstruction of the rotator cuff</description>
    <arm_group_label>PRF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Massive rotator cuff tears affecting supraspinatus and infraspinatus

          -  Failed conservative treatment for at least 6 months

          -  No hematologic disorder

        Exclusion Criteria:

          -  Rotator cuff affecting subscapularis

          -  chronic infectious disease

          -  anemia

          -  clot disorders

          -  low platelet count

          -  history of difficulty in venous puncture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel A Antuña, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>H. La PAz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raul Barco, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HU La PAz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose M Martinez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HU La Paz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose M sanchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HU La Paz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Jo CH, Kim JE, Yoon KS, Lee JH, Kang SB, Lee JH, Han HS, Rhee SH, Shin S. Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study. Am J Sports Med. 2011 Oct;39(10):2082-90. doi: 10.1177/0363546511413454. Epub 2011 Jul 7.</citation>
    <PMID>21737832</PMID>
  </reference>
  <reference>
    <citation>Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg. 2011 Jun;20(4):518-28. doi: 10.1016/j.jse.2011.02.008.</citation>
    <PMID>21570659</PMID>
  </reference>
  <reference>
    <citation>Castricini R, Longo UG, De Benedetto M, Panfoli N, Pirani P, Zini R, Maffulli N, Denaro V. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med. 2011 Feb;39(2):258-65. doi: 10.1177/0363546510390780. Epub 2010 Dec 15.</citation>
    <PMID>21160018</PMID>
  </reference>
  <results_reference>
    <citation>Barber FA, Hrnack SA, Snyder SJ, Hapa O. Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation. Arthroscopy. 2011 Aug;27(8):1029-35. doi: 10.1016/j.arthro.2011.06.010.</citation>
    <PMID>21802625</PMID>
  </results_reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2012</study_first_submitted>
  <study_first_submitted_qc>June 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2012</study_first_posted>
  <last_update_submitted>June 5, 2012</last_update_submitted>
  <last_update_submitted_qc>June 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>Samuel Antuna</investigator_full_name>
    <investigator_title>Consultant in Shoulder and Elbow Surgery</investigator_title>
  </responsible_party>
  <keyword>rotator cuff</keyword>
  <keyword>shoulder</keyword>
  <keyword>platelet rich plasma</keyword>
  <keyword>fibrin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

